Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes
Abstract Background The aim was to assess patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) treated with filgotinib during two phase 2b, 24-week, randomized, placebo-controlled studies. Methods Patients with moderate-to-severe active RA and an inadequate response to methotr...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2018-03-01
|
| Serier: | Arthritis Research & Therapy |
| Fag: | |
| Online adgang: | http://link.springer.com/article/10.1186/s13075-018-1541-z |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
